{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-215459","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2023-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.181817+00:00","generated_at":"2026-06-11T06:54:29.257661+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lantheus discontinues AZEDRA production; winds down Somerset, NJ site","bullets":["Progenics Pharmaceuticals subsidiary to stop manufacturing and promoting AZEDRA.","Limited usage and fixed costs made continued production untenable.","Goal to supply current patients through Q1 2024 to complete treatment.","Somerset, NJ manufacturing site being wound down.","No financial impact or restructuring charges disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-215459","json":"https://secwatch.observer/filing/0001193125-23-215459.json","markdown":"https://secwatch.observer/filing/0001193125-23-215459.md","text":"https://secwatch.observer/filing/0001193125-23-215459.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312523215459/0001193125-23-215459-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312523215459/d300211d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:54:29.257661+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}